These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11371515)

  • 1. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA.
    Geromel V; Kadhom N; Cebalos-Picot I; Ouari O; Polidori A; Munnich A; Rötig A; Rustin P
    Hum Mol Genet; 2001 May; 10(11):1221-8. PubMed ID: 11371515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
    Parfait B; de Lonlay P; von Kleist-Retzow JC; Cormier-Daire V; Chrétien D; Rötig A; Rabier D; Saudubray JM; Rustin P; Munnich A
    Eur J Pediatr; 1999 Jan; 158(1):55-8. PubMed ID: 9950309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome.
    Mordel P; Schaeffer S; Dupas Q; Laville MA; Gérard M; Chapon F; Allouche S
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):133-137. PubMed ID: 29054413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 depletion is comparatively less detrimental to human cultured skin fibroblasts than respiratory chain complex deficiencies.
    Geromel V; Rötig A; Munnich A; Rustin P
    Free Radic Res; 2002 Apr; 36(4):375-9. PubMed ID: 12069100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and preliminary biological evaluations of ionic and nonionic amphiphilic alpha-phenyl-N-tert-butylnitrone derivatives.
    Durand G; Polidori A; Ouari O; Tordo P; Geromel V; Rustin P; Pucci B
    J Med Chem; 2003 Nov; 46(24):5230-7. PubMed ID: 14613325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene.
    Rak M; Tetaud E; Duvezin-Caubet S; Ezkurdia N; Bietenhader M; Rytka J; di Rago JP
    J Biol Chem; 2007 Nov; 282(47):34039-47. PubMed ID: 17855363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of neurologic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome with a novel mitochondrial mutation m.8729 G>A].
    Miyawaki T; Koto S; Ishihara H; Goto Y; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2015; 55(2):91-5. PubMed ID: 25746071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioenergetics of mitochondrial diseases associated with mtDNA mutations.
    Lenaz G; Baracca A; Carelli V; D'Aurelio M; Sgarbi G; Solaini G
    Biochim Biophys Acta; 2004 Jul; 1658(1-2):89-94. PubMed ID: 15282179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant defence systems and generation of reactive oxygen species in osteosarcoma cells with defective mitochondria: effect of selenium.
    Wojewoda M; Duszyński J; Szczepanowska J
    Biochim Biophys Acta; 2010; 1797(6-7):890-6. PubMed ID: 20138159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
    Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
    Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NARP mutation and mtDNA depletion trigger mitochondrial biogenesis which can be modulated by selenite supplementation.
    Wojewoda M; Duszyński J; Szczepanowska J
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1178-86. PubMed ID: 21550418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mtDNA NARP mutation activates the actin-Nrf2 signaling of antioxidant defenses.
    Dassa EP; Paupe V; Gonçalves S; Rustin P
    Biochem Biophys Res Commun; 2008 Apr; 368(3):620-4. PubMed ID: 18261463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits.
    Bonnet C; Kaltimbacher V; Ellouze S; Augustin S; Bénit P; Forster V; Rustin P; Sahel JA; Corral-Debrinski M
    Rejuvenation Res; 2007 Jun; 10(2):127-44. PubMed ID: 17518546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993.
    Baracca A; Sgarbi G; Mattiazzi M; Casalena G; Pagnotta E; Valentino ML; Moggio M; Lenaz G; Carelli V; Solaini G
    Biochim Biophys Acta; 2007 Jul; 1767(7):913-9. PubMed ID: 17568559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes.
    Tsao CY; Mendell JR; Bartholomew D
    J Child Neurol; 2001 Jul; 16(7):533-5. PubMed ID: 11453454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex V (ATP synthase) deficiency].
    Nonaka I
    Ryoikibetsu Shokogun Shirizu; 2001; (36):142-3. PubMed ID: 11596347
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families.
    Uziel G; Moroni I; Lamantea E; Fratta GM; Ciceri E; Carrara F; Zeviani M
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):16-22. PubMed ID: 9221962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy.
    Sgarbi G; Casalena GA; Baracca A; Lenaz G; DiMauro S; Solaini G
    Arch Neurol; 2009 Aug; 66(8):951-7. PubMed ID: 19667215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
    Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
    Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.